Yeah I guess sidestep was a poor word choice. I just meant it seemed as though he was not at liberty to discuss it as this point in time. Which is understandable based on the situation.
And I concur. Quarter 1 I feel was all about laying the groundwork and further expanding on the foundation. Quarter 2 is about building on top of it. Upwards towards the sky. I hope Ifenprodil can start being used globally by end of the upcoming quarter. That would be amazing for all of us and for anyone out there suffering from lung damage due to COVID 19.
Looks like FDA has scheduled a 20 participant trial (Very low typically) to begin 6/20. At least there is efficacy in the FDA's opinion to move forward and can always be accelerated in light of the estimated completion date of 3/2021!
Study Type : Interventional (Clinical Trial) Estimated Enrollment : 20 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: An Open Label Study of the Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough Estimated Study Start Date : June 2020 Estimated Primary Completion Date : March 2021
News 
Market Data 
Discover 
